Literature DB >> 18337621

Proteasome inhibition potentiates the cytotoxic effects of hyperthermia in HT-29 colon cancer cells through inhibition of heat shock protein 27.

Fei Chen1, Reza Rezavi, Cha-Chi Wang, Lawrence E Harrison.   

Abstract

BACKGROUND: The purpose of this study was to investigate whether proteasome inhibition acts as a thermal sensitizing agent to induce tumor cell death in a colon cancer cell line.
METHODS: HT-29 colon cancer cells were exposed to hyperthermia (43 degrees C) in the presence of proteasome inhibition for 1 h. Viable cell mass and apoptosis were measured by MTT and annexin V staining, respectively. Protein levels were determined by Western blot analysis.
RESULTS: A significant synergistic effect on cell viability with proteasome inhibition was noted under hyperthermic conditions compared to hyperthermia alone (p < 0.05). Increases in phosphorylated ERK and decreases in HSP27 levels were observed in the cells exposed to proteasome inhibition at 43 degrees C. Pretreatment with an inhibitor of ERK yielded an additional increase in apoptosis when used in combination with proteasome inhibition and hyperthermia. Decreased expression of HSP27 by siRNA also resulted in increased thermally induced apoptotic cell death.
CONCLUSIONS: Thermal sensitization through proteasome inhibition may represent a novel approach to increase the efficacy of hyperthermia as an anticancer modality. (c) 2008 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18337621     DOI: 10.1159/000120997

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  4 in total

1.  Proteome profiling of heat shock of human primary breast epithelial cells, a dataset report.

Authors:  Min Jia; Serhiy Souchelnytskyi
Journal:  Cell Stress Chaperones       Date:  2011-01-11       Impact factor: 3.667

Review 2.  Thermal potentiation of chemotherapy by magnetic nanoparticles.

Authors:  Madeline Torres-Lugo; Carlos Rinaldi
Journal:  Nanomedicine (Lond)       Date:  2013-10       Impact factor: 5.307

Review 3.  Hyperthermia Treatment as a Promising Anti-Cancer Strategy: Therapeutic Targets, Perspective Mechanisms and Synergistic Combinations in Experimental Approaches.

Authors:  Ga Yeong Yi; Min Ju Kim; Hyo In Kim; Jinbong Park; Seung Ho Baek
Journal:  Antioxidants (Basel)       Date:  2022-03-24

4.  HIKESHI silencing can enhance mild hyperthermia sensitivity in human oral squamous cell carcinoma HSC‑3 cells.

Authors:  Yoshiaki Tabuchi; Keita Maekawa; Misako Torigoe; Yukihiro Furusawa; Tetsushi Hirano; Satsuki Minagawa; Tatsuya Yunoki; Atsushi Hayashi
Journal:  Int J Mol Med       Date:  2020-04-28       Impact factor: 4.101

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.